Morgan Stanley Maintains Overweight on Liberty Energy, Lowers Price Target to $20
Morgan Stanley analyst Connor Lynagh maintains Liberty Energy (NYSE:LBRT) with a Overweight and lowers the price target from $23 to $20.
Goldman Sachs Maintains Neutral on Cosan, Lowers Price Target to $15.6
Goldman Sachs analyst Bruno Amorim maintains Cosan (NYSE:CSAN) with a Neutral and lowers the price target from $19.2 to $15.6.
Morgan Stanley Maintains Overweight on Patterson-UTI Energy, Lowers Price Target to $18
Morgan Stanley analyst Connor Lynagh maintains Patterson-UTI Energy (NASDAQ:PTEN) with a Overweight and lowers the price target from $20 to $18.
Morgan Stanley Maintains Equal-Weight on Cactus, Lowers Price Target to $50
Morgan Stanley analyst Connor Lynagh maintains Cactus (NYSE:WHD) with a Equal-Weight and lowers the price target from $60 to $50.
Goldman Sachs Maintains Neutral on Warby Parker, Lowers Price Target to $16
Goldman Sachs analyst Brooke Roach maintains Warby Parker (NYSE:WRBY) with a Neutral and lowers the price target from $18 to $16.
Truist Securities Maintains Buy on Intuitive Surgical, Lowers Price Target to $270
Truist Securities analyst Richard Newitter maintains Intuitive Surgical (NASDAQ:ISRG) with a Buy and lowers the price target from $355 to $270.
Truist Securities Maintains Buy on Callon Petroleum, Lowers Price Target to $94
Truist Securities analyst Neal Dingmann maintains Callon Petroleum (NYSE:CPE) with a Buy and lowers the price target from $101 to $94.
Truist Securities Maintains Buy on ConocoPhillips, Lowers Price Target to $123
Truist Securities analyst Neal Dingmann maintains ConocoPhillips (NYSE:COP) with a Buy and lowers the price target from $126 to $123.
Evercore ISI Group Downgrades Bath & Body Works to In-Line, Lowers Price Target to $28
Evercore ISI Group analyst Omar Saad downgrades Bath & Body Works (NYSE:BBWI) from Outperform to In-Line and lowers the price target from $60 to $28.
Evercore ISI Group Downgrades Hanesbrands to In-Line, Lowers Price Target to $12
Evercore ISI Group analyst Omar Saad downgrades Hanesbrands (NYSE:HBI) from Outperform to In-Line and lowers the price target from $18 to $12.